New Product Development (NPD) for 2025

By Dr Brad McEwen PhD, MHSc, MPH, BHSc

CMG Head of Products and Innovation

2024 marked a significant period for the industry, characterised by substantial new product development (NPD) and overall industry growth. At present, the Australian complementary medicines industry is valued at an impressive $6.2 billion annually. There has been a surge in consumer interest and engagement in complementary medicines.

Approximately 75% of households across the nation utilise complementary medicines into their health and wellness routines, with mental health emerging as the primary health concern. Engaging in NPD is crucial for strengthening your brand and achieving a more pronounced presence in the market.

Overall, 2024 has set the stage for a transformative era in the complementary medicines industry, characterised by a robust market presence, a focus on mental health, and a commitment to delivering safe and effective products that resonate with the needs of consumers.

Dr Brad serves as the Head of Products and Innovation here at CMG. His role involves overseeing the development of cutting-edge health products and ensuring compliance with regulatory standards. In 2024, he received the Complementary Medicines Industry Contributor of the Year award. Dr Brad’s tips for NPD in 2025:

 

CMG is the manufacturer of choice for your products and NPD. For more information on manufacturing your products, contact us on info@cmgrouponline.com.au . Additionally, you can call us on 02 9091 0264 to organise a visit to our state-of-the-art factory in Warriewood, NSW. We welcome you to visit and tour our factory and see everything in action.

 

Leave a Reply

Your email address will not be published. Required fields are marked *